US Drug Recall Register
Class III · Low risk Ongoing Initiated Jun 29, 2022 (4 years ago)

Aspirin and Extended-Release Dipyridamole Capsules, 25mg/200 mg, 60-count bottle, Rx…

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Tablet/Capsule Specification : Capsule breakage

What was recalled

Aspirin and Extended-Release Dipyridamole Capsules, 25mg/200 mg, 60-count bottle, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India, NDC 68462-405-60.

Recalling firm
Glenmark Pharmaceuticals Inc., USA
NDC code
68462-405-60
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1282-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Aspirin recalls

See all